
Polmacoxib (2mg) + Paracetamol (325mg)
Active composition
+1 more active ingredient
Polmacoxib selectively inhibits COX-2, reducing the synthesis of inflammatory prostaglandins and alleviating pain.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Justpolma-P Tablet contains Polmacoxib 2mg and Paracetamol 325mg, combining the therapeutic effects of a selective COX-2 inhibitor and an analgesic-antipyretic agent. Polmacoxib, a novel nonsteroidal anti-inflammatory drug (NSAID), selectively inhibits cyclooxygenase-2 (COX-2), thereby reducing inflammation and pain with a lower risk of gastrointestinal side effects compared to traditional NSAIDs. Paracetamol, also known as acetaminophen, provides effective analgesic and antipyretic action by inhibiting prostaglandin synthesis in the central nervous system. This combination is indicated for the management of mild to moderate pain associated with musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, and postoperative pain, as well as for reducing fever. Justpolma-P Tablet offers rapid onset of pain relief with sustained anti-inflammatory benefits, improving patient compliance and comfort. It is generally well tolerated; however, caution is advised in patients with hepatic or renal impairment, cardiovascular disease, or gastrointestinal disorders. Concomitant use with other NSAIDs or hepatotoxic drugs should be avoided. Dosage should be individualized based on clinical response and patient tolerance. Consultation with a healthcare professional is recommended before initiating therapy to ensure safe and effective use.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Justpolma-P Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Justpolma-P Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Justpolma-P Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Justpolma-P Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Justpolma-P Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Justpolma-P Tablet

Polmacoxib (2mg) + Paracetamol (325mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Polmacoxib selectively inhibits COX-2, reducing the synthesis of inflammatory prostaglandins and alleviating pain.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Justpolma-P Tablet contains Polmacoxib 2mg and Paracetamol 325mg, combining the therapeutic effects of a selective COX-2 inhibitor and an analgesic-antipyretic agent. Polmacoxib, a novel nonsteroidal anti-inflammatory drug (NSAID), selectively inhibits cyclooxygenase-2 (COX-2), thereby reducing inflammation and pain with a lower risk of gastrointestinal side effects compared to traditional NSAIDs. Paracetamol, also known as acetaminophen, provides effective analgesic and antipyretic action by inhibiting prostaglandin synthesis in the central nervous system. This combination is indicated for the management of mild to moderate pain associated with musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, and postoperative pain, as well as for reducing fever. Justpolma-P Tablet offers rapid onset of pain relief with sustained anti-inflammatory benefits, improving patient compliance and comfort. It is generally well tolerated; however, caution is advised in patients with hepatic or renal impairment, cardiovascular disease, or gastrointestinal disorders. Concomitant use with other NSAIDs or hepatotoxic drugs should be avoided. Dosage should be individualized based on clinical response and patient tolerance. Consultation with a healthcare professional is recommended before initiating therapy to ensure safe and effective use.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Justpolma-P Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Justpolma-P Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Justpolma-P Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Justpolma-P Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Justpolma-P Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Justpolma-P Tablet











